IP Library Granted Patent US 9,445,870
Granted Patent B2
US 9,445,870 · App. 13/576,589 · Granted Sep 20, 2016

Methods and devices for crosslinking of corneal collagen and for treatment of disorders of the eye

Inventors: Roy S. Chuck (Great Neck, NY); Barbara Ann Soltz (Spring Valley, NY); Robert Soltz (Spring Valley, NY)
Assignees: Montefiore Medical Center; Conversion Energy Enterprises Inc.
A61B18/20A61F9/0079A61N5/062A61F2009/00872
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,445,870
App. No.
13/576,589
Granted
Sep 20, 2016
Kind
B2
Abstract

Methods and devices for delivering therapeutic or diagnostic energy (e.g., light, ultrasound, ionizing radiation (e.g., x-ray), vibration, heat energy, etc.) into the eye. An energy emitting device is positioned on the eye and used to deliver energy into the eye. The device may be constructed to allow the subject's eyelids to open and close while the device is positioned on the eye. The device is useable for various energy based or energy-mediated therapies, including crosslinking of corneal collagen, light therapy, photodynamic therapy, photo-activation of drugs, etc.

Claims (17)

1. A method for delivering therapeutic energy to an eye of a human or animal subject, said method comprising the steps of:

a) administering a crosslinking agent to the eye; and

b) placing on the subject's eye an ultraviolet light-emitting contact lens that allows the eye lids of that eye to open and close while the ultraviolet light-emitting contact lens is positioned on the eye, and causing the ultraviolet light-emitting contact lens positioned on the eye to deliver therapeutic energy into the eye sufficient to effect crosslinking of corneal collagen.

2. The method according to claim 1 wherein the contact lens emits ultraviolet light into the cornea of the subject's eye.

3. The method according to claim 2 wherein the ultraviolet light entering the cornea causes a photo-antimicrobial effect.

4. The method according to claim 1 wherein the agent comprises riboflavin.

5. The method according to claim 1 wherein the contact lens comprises a lens body and at least one light emitter.

6. The method according to claim 1 wherein the contact lens emits ultraviolet A light.

7. The method according to claim 6 wherein the ultraviolet A light is emitted with fluence of 5.4 mJ/cm 2 with a corresponding irradiance of 3 mW/cm 2 .

8. The method according to claim 6 wherein the contact lens emits light having a wavelength of 360 to 370 nanometers.

9. The method according to claim 6 wherein the contact lens emits light having a wavelength of 365 nm.

10. The method according to claim 6 wherein the contact lens emits light having an intensity of about 3 mW/cm2 for a desired period of time.

11. The method according to claim 6 wherein the light is delivered into the cornea for at least 30 minutes.

12. The method according to claim 1 wherein the contact lens comprises a light emitter of a type selected from the group consisting of: light emitting diodes (LEDs), micro light emitting diodes (micro LEDs), laser diodes, blue micro LEDs, light emitting chips, light emitting semiconductors, microchip lasers and other emitters of UVA or blue light.

13. The method according to claim 1 wherein the agent is applied topically to the cornea.

14. The method according to claim 1 wherein the agent is initially on or in the contact lens and is subsequently delivered from the contact lens into the eye.

15. The method according to claim 1 further comprising the step of removing or disrupting at least a portion of an epithelial layer on the cornea of the eye.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2013
From: SOLTZ, BARBARA ANN; SOLTZ, ROBERT
To: CONVERSION ENERGY ENTERPRISES INC.
Reel/Frame 030247/0471 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2012
From: CHUCK, ROY S.
To: MONTEFIORE MEDICAL CENTER
Reel/Frame 028778/0409 →
Continuity (2)
Provisional Application 61337271 · Feb 1, 2010
Related Publication 20130211389A1 · Aug 15, 2013